Skip to main content
  • linkedin
New Website Coming Soon!
Hit enter to search or ESC to close
Close Search
Hepion PharmaceuticalsHepion Pharmaceuticals
Menu
  • About
    • Company Overview
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Partnering
  • Liver Disease
    • Overview
    • Non-alcoholic Steatohepatitis (NASH)
    • Hepatocellular Carcinoma (HCC)
    • Viral Hepatitis
  • AI-POWR™
  • Pipeline
    • Overview
    • Rencofilstat
    • Therapeutic Strategy
    • Clinical Trials
    • Publications
    • Expanded Access Policy
  • Newsroom
  • Investors
    • Investor Overview
    • Press Releases
    • Events
    • Presentations
    • Company Information
    • Stock Information
    • SEC Filings
    • Corporate Governance
  • Contact
    • Contact Us
    • Careers
    Hepion Pharmaceuticals

    Hepion in the News

     About Hepion
    Recent News
     Contact Us
    Hepion
    Hepion In Media Placements

    Hepatitis Quest Moves From C to B Under Ex-Gilead Leaders [via Bloomberg Business]

    http://www.bloomberg.com/news/articles/2015-02-04/hepatitis-quest-moves-from-c-to-b-under-former-gilead-executives
    Hepion
    Hepion In Media Placements

    Hepion Obtains HBV Candidate, Investment from Chimerix

    http://www.biocentury.com/dailynews/company/2014-12-18/contravir-obtains-hbv-candidate-investment-from-chimerix
    • « Previous
    • 1
    • …
    • 3
    • 4
    • 5
    Share Share Share

    Media Contact

    info@hepionpharma.com

    Tweets by Hepion Pharma
    Get Important News and Updates by Email Subscribe
    • linkedin

    © 2026 Hepion Pharmaceuticals | Disclaimer & Terms of Use | WDDI

    Close Menu
    • About
      • Company Overview
      • Executive Team
      • Board of Directors
      • Scientific Advisory Board
      • Partnering
    • Liver Disease
      • Overview
      • Non-alcoholic Steatohepatitis (NASH)
      • Hepatocellular Carcinoma (HCC)
      • Viral Hepatitis
    • AI-POWR™
    • Pipeline
      • Overview
      • Rencofilstat
      • Therapeutic Strategy
      • Clinical Trials
      • Publications
      • Expanded Access Policy
    • Newsroom
    • Investors
      • Investor Overview
      • Press Releases
      • Events
      • Presentations
      • Company Information
      • Stock Information
      • SEC Filings
      • Corporate Governance
    • Contact
      • Contact Us
      • Careers
    • linkedin